Researchers discover surprising drug that blocks malaria

Jan 16, 2007

Northwestern University researchers have discovered how malaria parasites persuade red blood cells to engulf them -- and how to block the invading parasites. The malaria marauders hack into the red cell's signaling system and steal the molecular equivalent of its password to spring open the door to the cell. But researchers have found that a common blood pressure medication – propranolol – jams the signal to prevent the parasite from breaking in.

Scientists had long been perplexed by malaria's ability to hijack red blood cells, then wildly multiply and provoke its life-threatening symptoms.

"This opens the possibility for important new drugs for malaria that won't become resistant. New drugs are urgently needed because the parasite has evolved resistance against virtually all types of commonly used drugs," said Kasturi Haldar, principal investigator for the study and the Charles E. and Emma H. Morrison Professor in the department of pathology at the Feinberg School of Medicine at Northwestern. Sean Murphy, a Medical Sciences Training Program student, is the study's lead author.

The study was published in PLoS Medicine.

Malaria, one of the top three deadliest diseases in the developing world, is resurging worldwide because of drug resistance and the lack of an effective vaccine, Haldar said. Jamaica recently reported an outbreak of malaria after it had been eradicated in that country for 50 years.

A blood-borne illness, malaria is transmitted by infected mosquitoes. The symptoms include high fevers and flu-like symptoms such as chills, headache, muscle aches and fatigue. The disease kills an estimated 2 million people a year, mostly African children under five. It also poses a risk to travelers. An estimated 500 million cases of malaria were expected in 2006.

Commonly used drugs against malaria attack the parasite, but it rapidly changes its molecular structure to become resistant to those drugs. It would be difficult, however, for the malaria parasite to develop resistance to a drug that acts on a person's red blood cells as the blood pressure medication does, Haldar said.

When Haldar and her colleagues tested propranolol in combination with existing anti-malarial drugs in human cell cultures and mice, it reduced the dose of the anti-malarial drugs needed to kill the parasites by tenfold. That's significant because high doses of anti-malarial drugs – increasingly necessary as resistance to them builds -- can be toxic. In addition, blood pressure medication like propranolol is cheap and safe for use even in pregnant women, a group particularly vulnerable to malaria.

"We're working on developing a unique drug that would combine anti-malarial drugs with blood pressure medication. We think it has a high likelihood of success," Haldar said. The next step is human clinical trials.

Source: Northwestern University

Explore further: Infant cooing, babbling linked to hearing ability

add to favorites email to friend print save as pdf

Related Stories

Some anti-inflammatory drugs affect more than their targets

Aug 21, 2014

Researchers have discovered that three commonly used nonsteroidal anti-inflammatory drugs, or NSAIDs, alter the activity of enzymes within cell membranes. Their finding suggests that, if taken at higher-than-approved ...

An easier way to manipulate malaria genes

Aug 11, 2014

Plasmodium falciparum, the parasite that causes malaria, has proven notoriously resistant to scientists' efforts to study its genetics. It can take up to a year to determine the function of a single gene, ...

The 'yin and yang' of malaria parasite development

Jul 09, 2014

Scientists searching for new drug and vaccine targets to stop transmission of one of the world's deadliest diseases believe they are closer than ever to disrupting the life-cycle of this highly efficient ...

Recommended for you

Infant cooing, babbling linked to hearing ability

5 hours ago

Infants' vocalizations throughout the first year follow a set of predictable steps from crying and cooing to forming syllables and first words. However, previous research had not addressed how the amount ...

Developing 'tissue chip' to screen neurological toxins

6 hours ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

10 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

12 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

User comments : 0